ResumoOBJETIVO: Pesquisar o impacto da gestação na função sexual feminina. MÉTODOS: Foi realizado um estudo analítico, do tipo transversal, com 181 mulheres não gestantes e 177 gestantes. Foram incluídas mulheres com idade entre 18 e 45 anos, gestantes e não gestantes, na pré-menopausa, sexualmente ativas e com parceiro fixo e excluídas aquelas em uso de antidepressivos ou com diagnóstico de depressão. Dessas, 11 (6,2%) encontravam-se no primeiro trimestre; 50 (28,2%), no segundo e 116 (65,5%), no terceiro. A avaliação se deu por entrevista na qual foi aplicado o Índice de Função Sexual Feminina (IFSF). Os dados foram analisados através do programa Statistical Package for Social Sciences (SPSS) versão 16.0. Para a comparação entre as médias do IFSF entre gestantes e não gestantes, utilizou-se o teste não paramétrico de Mann-Whitney. RESULTADOS: A disfunção sexual entre gestantes foi de 40,4% e entre não gestantes de 23,3%, sendo significativa a diferença entre os escores dos grupos estudados (p=0,01). Também foi significativa (p<0,0001) a diferença entre as médias globais do IFSF entre os grupos. Foram observadas diferenças significativas entre gestantes e não gestantes no tocante aos escores dos domínios desejo (p<0,0001), excitação (p=0,003), lubrificação (p=0,02), orgasmo (p=0,005) e satisfação (p=0,03). O mesmo não foi observado no domínio dor. CONCLUSÃO: Diante dos resultados, concluímos que a gestação influencia negativamente a função sexual feminina, particularmente nos domínios desejo e excitação, revelando a importância da abordagem do tema pelos profissionais que lidam com gestantes. Abstract PURPOSE:To investigate the impact of pregnancy on female sexual function. METHODS: An analytical, crosssectional study was conducted on 181 non-pregnant and 177 pregnant women aged 18 to 45 years. The study included premenopausal, sexually active women with a steady partner and excluded those taking antidepressants or with a diagnosis of depression. Eleven of these women (6.2%) were in the first trimester, 50 (28.2%), in the second trimester and 116 (65.5%), in the third trimester of pregnancy. The evaluation consisted of an interview in which the Female Sexual Function Index (FSFI) was applied. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software, version 16.0. The nonparametric Mann-Whitney test was used to compare the mean FSFI values of pregnant and non-pregnant women. RESULTS: Sexual dysfunction was 40.4% among pregnant women and 23.3% among non-pregnant women, with a significant difference between the scores of the studied groups (p=0.01). The difference in the mean global FSFI values between the groups was also significant (p<0.0001). There were significant differences between pregnant and non-pregnant women regarding desire (p<0.0001), excitation (p=0.003), lubrication (p=0.02), orgasm (p=0.005) and satisfaction (p=0.03). The same was not observed regarding pain. CONCLUSION: We conclude that pregnancy negatively influences female sexual function, particularly the des...
Overall, ADRs were not common events among high-risk pregnant women and no adverse pregnancy outcomes following these events were observed.
Objective To evaluate the quality of the sexual function of women with suspected deep infiltrating endometriosis. Methods A cross-sectional, observational and prospective study was conducted between May 2015 and August 2016, in which 67 patients with deep infiltrating endometriosis, suspected or diagnosed, were assessed for epidemiological and clinical characteristics, such as pain level through a visual analog scale (VAS), features of deep infiltrating endometriosis lesions and score on the Female Sexual Function Index (FSFI) before the onset of treatment. The statistical analysis was performed using the software STATA version 12.0 (StataCorp LLC, College Station, TX, USA) to compare the variables through multiple regression analysis. Results The average age of the patients was 39.2 years old; most patients were symptomatic (92.5%); and the predominant location of the deep infiltrating lesions was on the rectosigmoid colon (50%), closely followed by the retrocervical region (48.3%). The median overall score on the FSFI was 23.4; in 67.2% of the cases the score was 26.5 (cutoff point for sexual dysfunction). Deep dyspareunia (p ¼ 0.000, confidence interval [CI]: 0.64-0.83) and rectosigmoid endometriosis lesions (p ¼ 0.008, CI: 0.72-0.95) showed significant correlation with lower FSFI scores, adjusted by bladder lesion, patients' age and size of lesions. Deep dyspareunia (p ¼ 0.003, CI: 0.49-0.86) also exhibited significant correlation with FSFI pain domain, adjusted by cyclic bowel pain, vaginal lesion and use of gonadotropin-releasing hormone (GnRH) analog. These results reflect the influence of deep dyspareunia on the sexual dysfunction of the analyzed population. Conclusion Most patients exhibited sexual dysfunction, and deep dyspareunia was the pelvic painful symptom that showed correlation with sexual dysfunction. ResumoObjetivo Avaliar a qualidade da função sexual em pacientes com suspeita de endometriose profunda infiltrativa. Métodos Foi realizado um estudo observacional transversal prospectivo entre maio de 2015 e agosto de 2016, no qual foram analisados os dados clínicos e
Objetivo: Verificar se há diferença na prevalência de disfunção sexual e nos escores dos domínios da função sexual entre grupos de mulheres portadoras do vírus HIV (MP) e de não portadoras (MNP), e apurar se há associação entre disfunção sexual e uso de terapia antirretroviral (TARV). Métodos: Estudo transversal composto por 244 mulheres sexualmente ativas, das quais 123 são MP e 121 são MNP. A função sexual foi avaliada pelo Quociente Sexual-versão feminina (QS-F). Resultados: Houve diferença significativa na prevalência de disfunção sexual entre MP e MNP (25,2 e 9,9%, p= 0,002) e nos escores dos domínios da função sexual: desejo (p<0,001) e orgasmo (p<0,01). Não houve diferença significativa na prevalência de disfunção sexual entre as usuárias de TARV e as não usuárias. Conclusões: Houve maior prevalência de disfunção sexual em MP. O uso de TARV não se associou a aumento na prevalência de disfunção sexual.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.